0 comments on “(Part 3) The Data “Revolution” in Healthcare: Obstacles and Opportunities”

(Part 3) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part Three: Election Day special: Regulatory Obstacles (continued from Part Two) By Ellen Martin Here is a 352-page description of US healthcare regulation as of 2006: Robert I. Field’s Health Care Regulation in America: Complexity, Confrontation, and Compromise. Click Here It is always…

0 comments on “(Part 2) The Data “Revolution” in Healthcare: Obstacles and Opportunities”

(Part 2) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part Two: Healthcare Structural Issues (continued from Part One) By Ellen Martin First, let’s recognize the fundamental market disconnect between providers, consumers (patients) and (third-party) payers (employers, insurance companies, managed care), which is a fundamental reason that healthcare is not a…

0 comments on “(Part 1) The Data “Revolution” in Healthcare: Obstacles and Opportunities”

(Part 1) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part One: Introduction By Ellen Martin As evidenced by StrataRx, as well as our Hype and Hope white paper, expectations run high regarding data’s potential to transform healthcare: lower costs, fewer errors, and better patient outcomes. So high, indeed, as…